Homeostatic cytokines and expansion of regulatory T cells accompany thymic impairment in children with Down syndrome

Rejuvenation Research

Volumn 11, Issue 3, 2008, Pages 573-583

  Roat, Erika ^a   Prada, Nicole ^a   Lugli, Enrico ^a   Nasi, Milena ^a   Ferraresi, Roberta ^a   Troiano, Leonarda ^a   Giovenzana, Chiara ^a   Pinti, Marcello ^a   Biagioni, Ornella ^b   Mariotti, Mauro ^b   Di Iorio, Angelo ^c   Consolo, Ugo ^a   Balli, Fiorella ^a   Cossarizza, Andrea ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b AUSL Modena   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD45RA ANTIGEN; FAS ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; T LYMPHOCYTE RECEPTOR;

APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; HOMEOSTASIS; HUMAN; HUMAN CELL; MALE; MEMORY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; THYMUS DISEASE; THYMUS FUNCTION;

CELL DIFFERENTIATION; CHILD; CHILD, PRESCHOOL; CYTOKINES; DOWN SYNDROME; FEMALE; HOMEOSTASIS; HUMANS; IMMUNOLOGIC MEMORY; INFANT; INTERLEUKIN-15; INTERLEUKIN-7; LYMPHOCYTE ACTIVATION; MALE; RECEPTORS, INTERLEUKIN-7; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND;

EID: 46449104782     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2007.0648     Document Type: Article

References (50)

1. Nelson DL, Gibbs RA. Genetics The critical region in trisomy 21. Science 2004;306:619-621.
2. Montagna D, Maccario R, Ugazio A G, Nespoli L, Pedroni E, Faggiano P, Burgio GR. Cell-mediated cytotoxicity in Down syndrome: impairment of allogeneic mixed lymphocyte reaction, NK and NK-like activities. Eur J Pediatr 1988;148:53-57.
3. Cossarizza, A, Monti D, Montagnani G, Forabosco A, Dagna-Bricarelli F, Franceschi C. Fetal thymic differentiation in Down's syndrome. Thymus 1989;14:163-170.
4. Park, E, Alberti J, Mehta P, Dalton A, Sersen E, Schuller-Levis G. Partial impairment of immune functions in peripheral blood leukocytes from aged men with Down's syndrome. Clin Immunol 2000;95:62-69.
5. Levin S. The immune system and susceptibility to infections in Down's syndrome. Prog Clin Biol Res 1987;246:143-162.
6. Reuland-Bosma W, van Dijk J. Periodontal disease in Down's syndrome: a review. J Clin Periodontol 1986;13:64-73.
7. Kinik ST, Ozcay F, Varan B. Type I diabetes mellitus, Hashimoto's thyroiditis and celiac disease in an adolescent with Down syndrome. Pediatr Int 2006;48:433-435.
8. Hitzler JK, Zipursky A. Origins of leukaemia in children with Down syndrome. Nat Rev Cancer 2005;5:11-20.
9. Barrena MJ, Echaniz P, Garcia-Serrano C, Cuadrado E. Imbalance of the CD4+ subpopulations expressing CD45RA and CD29 antigens in the peripheral blood of adults and children with Down syndrome. Scand J Immunol 1993;38:323-326.
10. Larocca LM, Piantelli M, Valitutti S, Castellino F, Maggiano N, Musiani P. Alterations in thymocyte subpopulations in Down's syndrome (trisomy 21). Clin Immunol Immunopathol 1988;49:175-186.
11. Papadopoulos N, Simopoulos C, Venizelos J, Kotini A, Skaphida P, Tamiolakis D. Fetal thymic medulla functional alterations in Down's syndrome. Minerva Med 2003;94:181-185.
12. Murphy M, Epstein LB. Down syndrome (DS) peripheral blood contains phenotypically mature CD36+TCR alpha, beta+ cells but abnormal proportions of TCR alpha, beta+, TCR gamma, delta+, and CD4+ CD45RA+ cells: evidence for an inefficient release of mature T cells by the DS thymus. Clin Immunol Immunopathol 1992;62:245-251.
13. de Hingh YC, van der Vossen PW, Gemen E F, Mulder AB, Hop WC, Brus F, de Vries E. Intrinsic abnormalities of lymphocyte counts in children with Down syndrome. J Pediatr 2005;147:744-747.
14. Benicchi T, Ghidini C, Re A, Cattaneo C, Casari S, Caimi L, Rossi G, Imberti L. T-cell immune reconstitution after hematopoietic stem cell transplantation for HIV-associated lymphoma. Transplantation 2005;80:673-682.
15. Fry TJ, Connick E, Falloon J, Lederman MM, Liewehr DJ, Spritzler J, Steinberg SM, Wood LV, Yarchoan R, Zuckerman J, Landay A, Mackall CL. A potential role for interleukin-7 in T-cell homeostasis. Blood 2001;97:2983-2990.
16. Bolotin E, Annett G, Parkman R, Weinberg K. Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count. Bone Marrow Transplant 1999;23:783-788.
17. Surh CD, Sprent J. Regulation of mature T cell homeostasis. Semin Immunol 2005;17:183-191.
18. Jameson SC. Maintaining the norm: T-cell homeostasis. Nat Rev Immunol 2002;2:547-556.
19. Akbar AN, Vukmanovic-Stejic M, Taams LS, Macallan DC. The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery. Nat Rev Immunol 2007;7:231-237.
20. Nasi M, Troiano L, Lugli E, Pinti M, Ferraresi R, Monterastelli E, Mussi C, Salvioli G, Franceschi C, Cossarizza A. Thymic output and functionality of the IL-7/IL-7 receptor system in centenarians: implications for the neolymphogenesis at the limit of human life. Aging Cell 2006;5:167-175.
21. Cossarizza A, Poccia F, Agrati C, D'Offizi G, Bugarini R, Pinti M, Borghi V, Mussini C, Esposito R, Ippolito G, Narciso P. Highly active antiretroviral therapy restores CD4+ Vbeta T-cell repertoire in patients with primary acute HIV infection but not in treatment-naive HIV+ patients with severe chronic infection. J Acquir Immune Defic Syndr 2004;35:213-222.
22. Pinti M, Troiano L, Nasi M, Bellodi C, Ferraresi R, Mussi C, Salvioli G, Cossarizza A. Balanced regulation of mRNA production for Fas and Fas ligand in lymphocytes from centenarians: how the immune system starts its second century. Circulation 2004;110:3108-3114.
23. Weston A, Parish C. New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy. J Immunol Methods 1990;133:87-97.
24. Tirelli G, Sidari L, Giacomarra V, Papanikolla L, Sasso F, Russolo M, Melato M. Do Ki67, S-phase, S + G2M and DNA ploidy, evaluated by flow cytometry, reveal locoregional metastasis in oral cavity and oropharynx carcinomas? Oncol Rep 2002;9:575-580.
25. Fabris N, Mocchegiani E, Amadio L, Zannotti M, Licastro F, Franceschi C. Thymic hormone deficiency in normal ageing and Down's syndrome: is there a primary failure of the thymus? Lancet 1984;1:983-986.
26. Muraro PA, Douek DC, Packer A, Chung K, Guenaga FJ, Cassiani-Ingoni R, Campbell C, Memon S, Nagle JW, Hakim FT, Gress RE, McFarland HF, Burt RK, Martin R. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 2005;201:805-816.
27. Diaz M, Douek DC, Valdez H, Hill BJ, Peterson D, Sanne I, Piliero PJ, Koup RA, Green SB, Schnittman S, Lederman MM. T cells containing T cell receptor excision circles are inversely related to HIV replication and are selectively and rapidly released into circulation with antiretroviral treatment. AIDS 2003;17:1145-1149.
28. Hazenberg MD, Verschuren MC, Hamann D, Miedema F, van Dongen JJ. T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation. J Mol Med 2001;79:631-640.
29. Douek DC, Betts MR, Hill BJ, Little SJ, Lempicki R, Metcalf JA, Casazza J, Yoder C, Adelsberger JW, Stevens RA, Baseler MW, Keiser P, Richman DD, Davey RT, Koup RA. Evidence for increased T cell turnover and decreased thymic output in HIV infection. J Immunol 2001;167:6663-6668.
30. Peled-Kamar M, Lotem J, Okon E, Sachs L, Groner Y. Thymic abnormalities and enhanced apoptosis of thymocytes and bone marrow cells in transgenic mice overexpressing Cu/Zn-superoxide dismutase: implications for Down syndrome. EMBO J 1995;14:4985-4993.
31. Ugazio AG, Maccario R, Notarangelo LD, Burgio GR. Immunology of Down syndrome: a review. Am J Med Genet Suppl 1990;7:204-214.
32. Noble RL, Warren RP. Altered T-cell subsets and defective T-cell function in young children with Down syndrome (trisomy-21). Immunol Invest 1987;16:371-382.
33. Cossarizza A., Ortolani C, Forti E, Montagnani G, Paganelli R, Zannotti M, Marini M, Monti D, Franceschi C. Age-related expansion of functionally inefficient cells with markers of natural killer activity in Down's syndrome. Blood 1991;77:1263-1270.
34. Cossarizza A, Monti D, Montagnani G, Ortolani C, Masi M, Zannotti M, Franceschi C. Precocious aging of the immune system in Down syndrome: alteration of B lymphocytes, T-lymphocyte subsets, and cells with natural killer markers. Am J Med Genet Suppl 1990;7:213-218.
35. Brunner T, Wasem C, Torgler R, Cima I, Jakob S, Corazza N. Fas (CD95/Apo-1) ligand regulation in T cell homeostasis, cell-mediated cytotoxicity and immune pathology. Semin Immunol 2003;15:167-176.
36. Samraj AK, Keil E, Ueffing N, Schulze-Osthoff K, Schmitz I. Loss of caspase-9 provides genetic evidence for the type I/II concept of CD95-mediated apoptosis. J Biol Chem 2006;281:29652-29659.
37. Fagnoni FF, Vescovini R, Passeri G, Bologna G, Pedrazzoni M, Lavagetto G, Casti A, Franceschi C, Passeri M, Sansoni P. Shortage of circulating naive CD8 (+) T cells provides new insights on immunodeficiency in aging. Blood 2000;95:2860-2868.
38. Jiang Q, Huang J, Li WQ, Cavinato T, Keller JR, Durum SK. Role of the intracellular domain of IL-7 receptor in T cell development. J Immunol 2007;178:228-234.
39. Goldrath AW, Bogatzki LY, Bevan MJ. Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J Exp Med 2000;192:557-564.
40. Park JH, Yu Q, Erman B, Appelbaum JS, Montoya-Durango D, Grimes HL, Singer A. Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizingIL-7-dependent T cell survival. Immunity 2004;21:289-302.
41. Goldrath AW, Sivakumar PV, Glaccum M, Kennedy MK, Bevan MJ, Benoist C, Mathis D, Butz EA. Cytokine requirements for acute and basal homeostatic proliferation of naive and memory CD8+ T cells. J Exp Med 2002;195:1515-1522.
42. Nemes E, Lugli E, Nasi M, Ferraresi R, Pinti M, Bugarini R, Borghi V, Prati F, Esposito R, Cossarizza A, Mussini C. Immunophenotype of HIV+ patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system. AIDS 2006;20:2021-2032.
43. Lee JH, Yu HH, Wang LC, Yang YH, Lin YT, Chiang BL. The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma. Clin Exp Immunol 2007;148:53-63.
44. Dejaco C, Duftner C, Schirmer M. Are regulatory T-cells linked with aging? Exp Gerontol 2006;41:339-345.
45. Picca CC, Larkin J 3rd, Boesteanu A, Lerman MA, Rankin AL, Caton AJ. Role of TCR specificity in CD4+ CD25+ regulatory T-cell selection. Immunol Rev 2006;212:74-85.
46. Kim JM, Rudensky A. The role of the transcription factor Foxp3 in the development of regulatory T cells. Immunol Rev 2006;212:86-98.
47. Wan YY, Flavell RA. The roles for cytokines in the generation and maintenance of regulatory T cells. Immunol Rev 2006;212:114-130.
48. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, Shimizu J, Takahashi T, Nomura T. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006;212:8-27.
49. Ruprecht CR, Gattorno M, Ferlito F, Gregorio A, Martini A, Lanzavecchia A, Sallusto F. Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J Exp Med 2005;201:1793-1803.
50. Zhou G, Levitsky HI. Natural regulatory T cells and de novo-induced regulatory T cells contribute independently to tumor-specific tolerance. J Immunol 2007;178:2155-2162.